Sulggi Lee, MD, PhD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-735-5127
Pronounsshe/her/hers
ORCID ORCID Icon0000-0003-1560-2250 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CAB.A.06/1998Human Biology
    University of Southern California, Los Angeles, CAM.D., Ph.D.06/2007Medicine, Genetic Epidemiology
    Stanford Hospital & Clinics, Stanford, CAResidency06/2010Internal Medicine
    University of California San Francisco, San Francisco, CAFellowship07/2013Infectious Diseases
    Collapse Awards and Honors
    UCSF Center for AIDS Research Program (CFAR)2018  - 2018Excellence in Translational Science Award

    Collapse Overview 
    Collapse Overview
    Sulggi Lee, MD PhD, is an Associate Professor of Medicine at the University of California, San Francisco (UCSF) and a faculty member in the Division of HIV, Infectious Diseases, and Global Medicine at the Zuckerberg San Francisco General Hospital. She is the PI of the UCSF Treat Acute HIV study, Co-PI of the UCSF SCOPE HIV cohort, the PI of the COVID-19 Host Immune Response Pathogenesis (CHIRP) study, Co-PI of the UCSF AIDS Cancer Specimen Resource (ACSR), and Co-Director of the UCSF Center for AIDS Research (CFAR) Bioinformatics Core. She is one of the founding executive committee members of the UCSF Women's Physician Scientist Supergroup (WPSS) and a faculty mentor for the UCSF Medical Scientist Training Program (MSTP) Community of Underrepresented Physician Scientists (CUPS) program. Her research focuses on clinical translational studies aimed at determining how natural host responses to pathogens (e.g., HIV, SARS-CoV-2) can be leveraged as future therapeutic targets using discovery-based analytic approaches. Her collaborative, interdisciplinary team includes data scientists, immunologists, virologists, and clinicians. Her work involves the application of highly advanced laboratory assays to well-characterized patient samples from observational studies and clinical trials. The goal of her research is to identify underlying host mechanisms of pathogen control to enable the identification of potential novel therapeutic targets for reducing morbidity and mortality associated with HIV and COVID-19.

    Collapse Research 
    Collapse Research Activities and Funding
    Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)
    NIH/NHLBI R01HL170600Jul 1, 2023 - Jun 30, 2028
    Role: Co-Investigator
    UCSF-Bay Area Center for AIDS Research
    NIH/NIAID 2 P30 AI027763-31Sep 1, 2022 - Aug 31, 2027
    Role: Co-Investigator, CFAR Bioinformatics Core Co-Director
    The heterogeneous HIV-expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound.
    NIH/NIAID P01AI169606May 1, 2022 - Apr 30, 2027
    Role: Co-Investigator
    MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
    NIH/NIAID R01 AI159260Jul 1, 2021 - Jun 30, 2026
    Role: Co-Investigator
    COVID-19 Host Immune Response Pathogenesis (CHIRP) Study
    Emergent Ventures at the Mercatus Center, George Mason University CA-0161832Aug 1, 2020 - Jul 31, 2024
    Role: Principal Investigator
    Evolutionary Dynamics of Viral Reservoir Cells
    Bill & Melinda Gates Foundation INV-002703Nov 1, 2019 - Oct 31, 2024
    Role: Co-Investigator
    AIDS and Cancer Specimen Resource
    NIH/NCI UM1 CA181255Sep 1, 2019 - Aug 31, 2024
    Role: Co-Principal Investigator
    Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
    NIH R01AI143464Jun 1, 2019 - May 31, 2024
    Role: Principal Investigator
    Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
    NIH R61DA047024Aug 1, 2018 - May 31, 2022
    Role: Principal Investigator
    Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection - Tissue-Based Studies
    Gilead Sciences IN-US-236-1354Jul 1, 2018 - Jul 1, 2021
    Role: Principal Investigator
    Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection
    VIiv Healthcare CA-0101618Apr 1, 2017 - Apr 30, 2020
    Role: Principal Investigator
    amfAR Institute for HIV Cure Research
    The Foundation for AIDS Research (amfAR) 109380-59-RGRLJan 1, 2016 - Dec 31, 2020
    Role: Co-Investigator; UCSF amfAR HIV Cure Institute Clinical Core Director
    A pharmacogenomics study of HIV latency: the role of PD-1 signaling
    NIH K23GM112526Aug 5, 2014 - Jul 31, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024 Feb; 25(2):218-225. Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young KC, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. PMID: 38212464; PMCID: PMC10834368.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    2. A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size. PLoS Pathog. 2023 Nov; 19(11):e1011114. Dwivedi AK, Gornalusse GG, Siegel DA, Barbehenn A, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Reppetti J, Vo PM, Levy CN, Roychoudhury P, Jerome KR, Hladik F, Henrich TJ, Deeks SG, Lee SA. PMID: 38019897; PMCID: PMC10712869.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Transient Anti-Interferon Auto Antibodies in the Airway Are Associated with Recovery in Mild COVID-19. Blood. 2023 Nov 28; 142(Supplement 1):156. Babcock BB, Kosters KA, Roan RN, Lee LS, Ghosn GE. .
      View in: Publisher Site   Mentions:
    4. Assessing the associations between known genetic variants and substance use in people with HIV in the United States. PLoS One. 2023; 18(10):e0292068. Haas CB, Jordahl KM, Nance RM, Whitney BM, Wang L, Delaney JAC, Ruderman S, Jia T, Mathews WC, Saag MS, Lee SA, Napravnik S, Jacobson JM, Chander G, McCall EM, Moore RD, Mayer KH, Mukherjee S, Lee WJ, Crane PK, Crane H, Peter I, Lindström S. PMID: 37796845; PMCID: PMC10553320.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    5. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023 Aug 04. Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young K, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. PMID: 36798286; PMCID: PMC9934605.
      View in: PubMed   Mentions:
    6. Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection. bioRxiv. 2023 Jan 12. Dwivedi AK, Siegel DA, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Levy CN, Roychoudhury P, Hladik F, Jerome KR, Henrich TJ, Deeks SG, Lee SA. PMID: 36712077; PMCID: PMC9882059.
      View in: PubMed   Mentions:
    7. Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size. AIDS. 2023 03 01; 37(3):477-488. Siegel DA, Thanh C, Wan E, Hoh R, Hobbs K, Pan T, Gibson EA, Kroetz DL, Martin J, Hecht F, Pilcher C, Martin M, Carrington M, Pillai S, Busch MP, Stone M, Levy CN, Huang ML, Roychoudhury P, Hladik F, Jerome KR, Kiem HP, Henrich TJ, Deeks SG, Lee SA. PMID: 36695358; PMCID: PMC9894159.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Common and Divergent Features of T Cells from Blood, Gut, and Genital Tract of Antiretroviral Therapy-Treated HIV+ Women. J Immunol. 2022 04 01; 208(7):1790-1801. Xie G, Moron-Lopez S, Siegel DA, Yin K, Polos A, Cohen J, Greenblatt RM, Tien PC, Lee SA, Yukl SA, Roan NR. PMID: 35296537; PMCID: PMC8976750.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals. Front Immunol. 2022; 13:803417. George AF, Luo X, Neidleman J, Hoh R, Vohra P, Thomas R, Shin MG, Lee MJ, Blish CA, Deeks SG, Greene WC, Lee SA, Roan NR. PMID: 35154118; PMCID: PMC8829545.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    10. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Elife. 2021 10 12; 10. Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, Lee SA, Roan NR. PMID: 34636722; PMCID: PMC8545397.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCellsPHPublic Health
    11. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence. J Immunol. 2021 09 01; 207(5):1344-1356. Ma T, Ryu H, McGregor M, Babcock B, Neidleman J, Xie G, George AF, Frouard J, Murray V, Gill G, Ghosn E, Newell EW, Lee SA, Roan NR. PMID: 34389625; PMCID: PMC8763019.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    12. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. bioRxiv. 2021 Jul 29. Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, Lee SA, Roan NR. PMID: 34013277; PMCID: PMC8132283.
      View in: PubMed   Mentions: 1  
    13. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep. 2021 07 20; 36(3):109414. Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee SA, Ghosn E, Lynch KL, Roan NR. PMID: 34260965; PMCID: PMC8238659.
      View in: PubMed   Mentions: 49     Fields:    
    14. No detectable alloreactive transcriptional responses under standard sample preparation conditions during donor-multiplexed single-cell RNA sequencing of peripheral blood mononuclear cells. BMC Biol. 2021 01 20; 19(1):10. McGinnis CS, Siegel DA, Xie G, Hartoularos G, Stone M, Ye CJ, Gartner ZJ, Roan NR, Lee SA. PMID: 33472616; PMCID: PMC7816397.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    15. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential. Cell Rep Med. 2020 09 22; 1(6):100081. Neidleman J, Luo X, Frouard J, Xie G, Gill G, Stein ES, McGregor M, Ma T, George AF, Kosters A, Greene WC, Vasquez J, Ghosn E, Lee S, Roan NR. PMID: 32839763; PMCID: PMC7437502.
      View in: PubMed   Mentions: 120     Fields:    
    16. Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection. PLoS Pathog. 2020 04; 16(4):e1008450. Hsiao F, Frouard J, Gramatica A, Xie G, Telwatte S, Lee GQ, Roychoudhury P, Schwarzer R, Luo X, Yukl SA, Lee S, Hoh R, Deeks SG, Jones RB, Cavrois M, Greene WC, Roan NR. PMID: 32353080; PMCID: PMC7192375.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    17. Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay. J Acquir Immune Defic Syndr. 2020 04 15; 83(5):530-537. Lee SA, Telwatte S, Hatano H, Kashuba ADM, Cottrell ML, Hoh R, Liegler TJ, Stephenson S, Somsouk M, Hunt PW, Deeks SG, Yukl S, Savic RM. PMID: 32168200; PMCID: PMC7286563.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    18. TCR+CD4-CD8- (double negative) T cells protect from cisplatin-induced renal epithelial cell apoptosis and acute kidney injury. Am J Physiol Renal Physiol. 2020 06 01; 318(6):F1500-F1512. Gong J, Noel S, Hsu J, Bush EL, Arend LJ, Sadasivam M, Lee SA, Kurzhagen JT, Hamad ARA, Rabb H. PMID: 32281417; PMCID: PMC7311707.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    19. OP 4.2 Characterising ‘exceptional’ control among HIV elite controllers. Journal of virus eradication. 2019 Dec 1; 5:31. Peluso PM, Burbelo BP, Kumar KS, Munter MS, Hoh HR, Lee LS, Hunt HP, Rutishauser RR, Henrich HT, Deeks DS. .
      View in: Publisher Site   Mentions:
    20. 20 Kansui, an ingenol-containing herbal supplement, safely induced CD8, NK, and monocyte activation in three ART-suppressed SIVmac251-infected rhesus macaques. Journal of virus eradication. 2019 Jul 1; 5:12-13. Lee LS, Kesmy KK, Bacchetti BP, Hoh HR, Lifson LJ, Cary CD, Peterlin PB, Deeks DS, Hartigan-O’Connor HD. .
      View in: Publisher Site   Mentions:
    21. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 04 01; 33(5):825-832. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. PMID: 30882490; PMCID: PMC7029629.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    22. Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2. J Am Soc Nephrol. 2019 02; 30(2):277-292. Sadasivam M, Noel S, Lee SA, Gong J, Allaf ME, Pierorazio P, Rabb H, Hamad ARA. PMID: 30622155; PMCID: PMC6362627.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    23. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. PMID: 30503324; PMCID: PMC6541554.
      View in: PubMed   Mentions: 28     Fields:    
    24. Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency. PLoS Pathog. 2018 11; 14(11):e1007357. Telwatte S, Lee S, Somsouk M, Hatano H, Baker C, Kaiser P, Kim P, Chen TH, Milush J, Hunt PW, Deeks SG, Wong JK, Yukl SA. PMID: 30440043; PMCID: PMC6237391.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    25. Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther. 2019 03; 105(3):692-702. Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM. PMID: 30137649; PMCID: PMC6379104.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    26. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Res Hum Retroviruses. 2018 11; 34(11):982-992. Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ. PMID: 29973058; PMCID: PMC6238612.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    27. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018 07; 71:108-115. Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, Shoptaw S, Flowers E, Dilworth SE, Pahwa S, Aouizerat BE. PMID: 29679637; PMCID: PMC6003871.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    28. PP4.10 HIV integrates in genes regulating cell cycle, DNA damage, and viral transport. Journal of virus eradication. 2017 Dec 1; 3:26. Lee LS, Haworth HK, Henrich HT, Deeks DS, Kiem KH. .
      View in: Publisher Site   Mentions:
    29. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2017 04 15; 215(8):1270-1274. Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW. PMID: 28329310; PMCID: PMC5853335.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    30. Efavirenz-metabolizing polymorphisms, viral suppression, and depression in HIV-infected individuals initiating antiretroviral therapy in southwestern Uganda. Open Forum Infectious Diseases. 2017 Jan 1; 4(suppl_1):s430-s431. Chang CJ, Lee LS, Hunt HP, Kroetz KD, Siedner SM. .
      View in: Publisher Site   Mentions:
    31. Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection. J Infect Dis. 2016 Oct 01; 214 Suppl 2:S44-50. Hunt PW, Lee SA, Siedner MJ. PMID: 27625430; PMCID: PMC5021241.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    32. The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough? EBioMedicine. 2016 Sep; 11:7-8. Lee SA, Deeks SG. PMID: 27515690; PMCID: PMC5049928.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    33. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy. PLoS One. 2016; 11(8):e0160192. Lee SA, Bacchetti P, Chomont N, Fromentin R, Lewin SR, O'Doherty U, Palmer S, Richman DD, Siliciano JD, Yukl SA, Deeks SG, Burbelo PD. PMID: 27483366; PMCID: PMC4970722.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    34. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS. 2016 07 17; 30(11):1807-15. Lee SA, Mefford JA, Huang Y, Witte JS, Martin JN, Haas DW, Mclaren PJ, Mushiroda T, Kubo M, Byakwaga H, Hunt PW, Kroetz DL. PMID: 27088321; PMCID: PMC4925250.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    35. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J Clin Invest. 2016 07 01; 126(7):2745-56. Younes SA, Freeman ML, Mudd JC, Shive CL, Reynaldi A, Panigrahi S, Estes JD, Deleage C, Lucero C, Anderson J, Schacker TW, Davenport MP, McCune JM, Hunt PW, Lee SA, Serrano-Villar S, Debernardo RL, Jacobson JM, Canaday DH, Sekaly RP, Rodriguez B, Sieg SF, Lederman MM. PMID: 27322062; PMCID: PMC4922693.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    36. Immunologic profiles distinguish aviremic HIV-infected adults. AIDS. 2016 06 19; 30(10):1553-62. Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, Hatano H, Conn D, Hecht FM, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 26854811; PMCID: PMC5679214.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    37. Reply to Barrett, et al. Clin Infect Dis. 2016 06 01; 62(11):1468-9. Freeman ML, Mudd JC, Shive CL, Younes SA, Panigrahi S, Sieg SF, Lee SA, Hunt PW, Calabrese LH, Gianella S, Rodriguez B, Lederman MM. PMID: 27001803; PMCID: PMC5006408.
      View in: PubMed   Mentions: 1     Fields:    
    38. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV. 2015 Dec; 2(12):e520-9. Elliott JH, McMahon JH, Chang CC, Lee SA, Hartogensis W, Bumpus N, Savic R, Roney J, Hoh R, Solomon A, Piatak M, Gorelick RJ, Lifson J, Bacchetti P, Deeks SG, Lewin SR. PMID: 26614966; PMCID: PMC5108570.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansCellsCTClinical Trials
    39. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection. Clin Infect Dis. 2016 Feb 01; 62(3):392-6. Freeman ML, Mudd JC, Shive CL, Younes SA, Panigrahi S, Sieg SF, Lee SA, Hunt PW, Calabrese LH, Gianella S, Rodriguez B, Lederman MM. PMID: 26400999; PMCID: PMC4706630.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    40. Highlights from the Keystone Symposium on HIV Persistence 2015: 26-30 April 2015, Boston, Massachusetts, USA. J Virus Erad. 2015 Jul 01; 1(3):225-6. Lee SA. PMID: 27482417; PMCID: PMC4946746.
      View in: PubMed   Mentions:
    41. Bartonella quintana Aortitis in a Man with AIDS, Diagnosed by Needle Biopsy and 16S rRNA Gene Amplification. J Clin Microbiol. 2015 Aug; 53(8):2773-6. Lee SA, Plett SK, Luetkemeyer AF, Borgo GM, Ohliger MA, Conrad MB, Cookson BT, Sengupta DJ, Koehler JE. PMID: 26063867; PMCID: PMC4508458.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    42. IL-15 drives CD8 T cell cycling and differentiation in chronic HIV-1 infection (VIR6P.1162). The Journal of Immunology. 2015 May 1; 194(1_Supplement):149.2-149.2. younes ys, shive sc, Reynaldi RA, Freeman FM, Panigrahi PS, Estes EJ, Anderson AJ, Schacker ST, Davenport DM, McCune MJ, Hunt HP, Lee LS, Serrano-Villar SS, Canaday CD, Cameron CC, Sekaly SR, Rodriguez RB, Sieg SS, Lederman LM. .
      View in: Publisher Site   Mentions:
    43. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014 May; 10(5):e1004078. Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG. PMID: 24831517; PMCID: PMC4022662.
      View in: PubMed   Mentions: 301     Fields:    Translation:HumansCells
    44. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis. 2014 Aug 01; 210(3):374-82. Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta M, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, Hunt PW. PMID: 24585893; PMCID: PMC4110459.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    45. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One. 2014; 9(2):e89444. Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, Bangsberg DR, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 24586783; PMCID: PMC3937334.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    46. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med Genet. 2007 Dec 01; 8:72. Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO. PMID: 18053149; PMCID: PMC2219987.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    47. Chapter 40 Body weight, menopausal hormone therapy, and risk of breast cancer. Treatment of the Postmenopausal Woman. 2007 Jan 1; (J Natl Cancer Inst481972):569-578. Wu WA, Pearce PC, Spicer SD, Lee LS, Pike PM. .
      View in: Publisher Site   Mentions:
    48. Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda. J Infect Dis. 2006 Apr 15; 193(8):1160-3. Lee SA, Yeka A, Nsobya SL, Dokomajilar C, Rosenthal PJ, Talisuna A, Dorsey G. PMID: 16544257.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    49. Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort. Int J Cancer. 2006 Mar 01; 118(5):1285-91. Lee S, Kolonel L, Wilkens L, Wan P, Henderson B, Pike M. PMID: 16170777.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    50. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer. 2005 Jun 06; 92(11):2049-58. Lee SA, Ross RK, Pike MC. PMID: 15900297; PMCID: PMC2361783.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    Sulggi's Networks
    Concepts (227)
    Derived automatically from this person's publications.
    _
    Co-Authors (65)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _